doxazosin has been researched along with Cancer of Endometrium in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karaca, B | 1 |
| Bakır, E | 1 |
| Yerer, MB | 1 |
| Cumaoğlu, A | 1 |
| Hamurcu, Z | 1 |
| Eken, A | 1 |
1 other study available for doxazosin and Cancer of Endometrium
| Article | Year |
|---|---|
Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways.
Topics: Antineoplastic Agents; beta Catenin; Doxazosin; Endometrial Neoplasms; Erlotinib Hydrochloride; Estr | 2021 |